1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Oligometastatic: new trials by email Literature Review of Oligometastatic trials Research Report on Oligometastatic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer Paclitaxel and Cisplatin/ Carboplatin, Iparomlimab and Tuvonralimab, Radiotherapy - Cervical Cancer, Neoplasm Recurrence, Local | Phase 2 | Recruiting | Shandong Cancer Hospital and Institute | 36 | 2025-02-28 | 2025-04-24 |
Neoplasm Recurrence, Local (1) · Neoplasms (1) · Uterine Cervical Neoplasms (1)
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Neoplasms by Site (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Uterine Cervical Diseases (1) · Uterine Diseases (1) · Uterine Neoplasms (1)
Carboplatin (1) · Cisplatin (1) · Paclitaxel (1) · Radiotherapy (1)
Shandong Cancer Hospital and Institute (1)
China (1)
Peng Xie (1)